Novo Nordisk’s new obesity drug could be set to transform obesity care, but there’s much more that pharma can do to help.

GSK’s Judy Stewart discusses her ambition to work in pharmaceuticals and make a difference to public health, the vast GSK vaccine pipeline, leadership and the importance of work-life balance.

What are the generation differences in how HCPs want to talk to pharma? Three generations of doctors share their thoughts.

AstraZeneca’s Mina Makar talks about solving unmet needs and how to champion the patient perspective.

Many top pharma companies have cut their Twitter ad spend after the Eli Lilly scandal, but should they take a risk and return?

Roche’s Davidek Herron offers five top tips for pharma teams striving for omnichannel excellence.

How can pharma maximise the impact of key opinion leaders in the ever-evolving digital world?

Medical affairs is becoming increasingly complex, but industry-academia collaboration aims to tackle this head on.